TEL AVIV, Israel, July 13, 2015 /PRNewswire/ --
Elbit Imaging Ltd. ("EI" or the
"Company") (TASE, NASDAQ: EMITF)
announced today that Plaza Centers N.V. (LSE:PLAZ) a
subsidiary of the Company, has appointed Mr. Akiva Azulay as its new President and CEO,
starting in August 2015.
Mr. Akiva Azulay joins Plaza with
a strong business management and financial background alongside
extensive real estate and retail experience. Akiva previously held
senior roles at some of the largest real estate and finance Israeli
companies. Most recently, Akiva was at Delek Group, one of
Israel's largest companies. Akiva
supported the company's activities in the UK and played a key role
on behalf of Delek in the eventual sale of a major UK real estate
led operational business, in September
2014. Akiva previously held senior roles at AFI Europe (part
of Africa-Israel Investments) between 2004 and 2010, most recently
as Vice President, where he managed real estate operations across
Central and Eastern Europe. Before
this, Akiva also worked at Bank Hapoalim, the largest Israeli Bank,
as an economist in the real estate investment department, handling
the provision of credit to construction and development projects in
Israel. Akiva holds a B.Sc and
M.Sc from Ben-Gurion University as well
as a certificate in real estate valuation and appraisal
certification from Tel-Aviv
University.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial centers - initiation, construction, and
sale of commercial centers and other mixed-use property projects,
predominantly in the retail sector, located in Central and
Eastern Europe and in India. In certain circumstances and depending
on market conditions, the Group operates and manages commercial
centers prior to their sale. (ii) Hotels - hotels operation and
management. (iii) Medical industries and devices - (a) research and
development, production and marketing of magnetic resonance imaging
guided focused ultrasound treatment equipment, and (b) development
of stem cell population expansion technologies and stem cell
therapy products for transplantation and regenerative medicine.
(iv) Residential projects - initiation, construction and sale of
residential units or plots designated for residential located
primarily in India.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
Any forward-looking statements in our releases include
statements regarding the intent, belief or current expectations of
Elbit Imaging Ltd. and our management about our business, financial
condition, results of operations, and its relationship with its
employees and the condition of our properties. Words such as
"believe," "would,"
"expect," "intend,"
"estimate" and similar expressions are
intended to identify forward-looking statements but are not the
exclusive means of identifying such statements. Actual results may
differ materially from those projected, expressed or implied in the
forward-looking statements as a result of various factors
including, without limitation, the factors set forth
in our filings with the Securities and Exchange Commission
including, without limitation, Item 3.D of our annual report on
Form 20-F for the fiscal year ended December
31, 2014, under the caption
"Risk Factors." Any forward-looking
statements contained in our releases speak only as of the date of
such release, and we caution existing and prospective investors not
to place undue reliance on such statements. Such forward-looking
statements do not purport to be predictions of future events or
circumstances, and therefore, there can be no assurance that any
forward-looking statement contained our releases will prove to be
accurate. We undertake no obligation to update or revise any
forward-looking statements.
For Further Information:
Company Contact
Ron Hadassi
Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com
SOURCE Elbit Imaging Ltd.